ICU Map
endocrine / metabolic

Hypothermic Bradycardic Coma / Myxedema Decompensation

Severe hypothyroid decompensation with altered consciousness, hypoventilation, hypothermia, bradycardia, hyponatremia or shock requiring immediate ICU therapy before confirmatory testing is complete.

Recognize

  • Suspect myxedema coma in severe hypothyroidism with altered consciousness plus hypothermia, bradycardia, hypoventilation/hypercapnia, hyponatremia, hypoglycemia, hypotension or a precipitating infection/drug exposure. Coma is not required. Draw TSH/free T4, cortisol, electrolytes, glucose, blood gas and cultures as indicated, but do not wait for results when the syndrome is compelling.

Act now — glucocorticoid first

  • Give empiric stress-dose IV glucocorticoid before or with thyroid hormone (commonly hydrocortisone 100 mg IV every 8 hours) until clinically important adrenal insufficiency is excluded, because thyroid replacement can increase cortisol clearance and precipitate adrenal collapse.

Act now — thyroid hormone

  • Give IV levothyroxine with an age/cardiac-risk-adjusted loading strategy followed by daily replacement. Use lower loading doses in older patients, coronary disease, arrhythmia or low body mass. Liothyronine is not routine and should be reserved for selected severe/refractory cases with specialist input because of cardiac risk.

Support physiology

Reassess

Caution

Do not warm aggressively with external heat that causes peripheral vasodilation and hypotension, and do not give thyroid hormone without first protecting against possible adrenal insufficiency.

Direct evidence for this problem

1 source
guideline•2026
Management of endocrine emergencies: joint consensus statement for management of myxoedema coma ↗

Current consensus for ICU myxedema-coma resuscitation, glucocorticoid and thyroid-hormone therapy.

Evidence status

Review metadata not yet recorded.

Status, review dates and guideline versions appear here once editorial metadata is authored for this content.